No abstract available
Publication types
-
Comment
-
Editorial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Angiotensin II Type 1 Receptor Blockers / therapeutic use
-
Antihypertensive Agents / therapeutic use
-
Atenolol / therapeutic use
-
Atrial Fibrillation / etiology
-
Atrial Fibrillation / physiopathology*
-
Atrial Fibrillation / prevention & control
-
Electrocardiography
-
Heart Rate* / drug effects
-
Humans
-
Hypertension / complications
-
Hypertension / drug therapy
-
Hypertension / physiopathology*
-
Hypertrophy, Left Ventricular / etiology
-
Hypertrophy, Left Ventricular / physiopathology*
-
Hypertrophy, Left Ventricular / prevention & control
-
Incidence
-
Losartan / therapeutic use
-
Reference Values
-
Risk Assessment
-
Risk Factors
-
Tachycardia / physiopathology*
-
Time Factors
-
Treatment Outcome
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin II Type 1 Receptor Blockers
-
Antihypertensive Agents
-
Atenolol
-
Losartan